Protein fragment complementation assays for the detection of biological or drug interactions
AssigneeOdyssey Pharmaceuticals, Inc.
InventorsStephen William Watson Michnick, Joelle Nina Pelletier, Ingrid Remy
Life of this patent
Estimating the term…
Loading patent…
AssigneeOdyssey Pharmaceuticals, Inc.
InventorsStephen William Watson Michnick, Joelle Nina Pelletier, Ingrid Remy
Estimating the term…
We describe a strategy for designing and implementing protein-fragment complementation assays (PCAs) to detect biomolecular interactions in vivo and in vitro. The design, implementation and broad applications of this strategy are illustrated with a large number of enzymes with particular detail provided for the example of murine dihydrofolate reductase (DHFR). Fusion peptides consisting of N- and C-terminal fragments of murine DHFR fused to GCN4 leucine zipper sequences were coexpressed in Escherichia coli grown in minimal medium, where the endogenous DHFR activity was inhibited with trimethoprim. Coexpression of the complementary fusion products restored colony formation. Survival only occurred when both DHFR fragments were present and contained leucine-zipper forming sequences, demonstrating that reconstitution of enzyme activity requires assistance of leucine zipper formation. DHFR fragment-interface point mutants of increasing severity (lle to Val, Ala and Gly) resulted in a sequential increase in E. coli doubling times illustrating the successful DHFR fragment reassembly rather than non-specific interactions between fragments. This assay could be used to study equilibrium and kinetic aspects of molecular interactions including protein-protein, protein-DNA, protein-RNA, protein-carbohydrate and protein-small molecule interactions, for screening cDNA libraries for binding of a target protein with unknown proteins or libraries of small organic molecules for biological activity. The selection and design criteria applied here is developed for numerous examples of clonal selection, colorometric, fluorometric and other assays based on enzymes whose products can be measured. The development of such assay systems is shown to be simple, and provides for a diverse set of protein fragment complementation applications.
Protein fragment complementation assays for the detection of molecular interactions comprising a reassembly of separate fragments of an enzyme wherein reassembly of the enzyme fragments is operated by the interaction of molecular domains fused to each enzyme fragment, wherein reassembly of the enzyme fragments is independent of other molecular processes and wherein said reassembly is detected by means of reconstitution of activity of said enzyme.
A method for detecting biomolecular interactions said method comprising:
A method of testing biomolecular interactions comprising:
A method comprising an assay where fragments of a first enzyme molecule are fused to a second molecule and fragment association is detected by reconstitution of the first enzyme molecule's activity.
A composition comprising a product selected from the group consisting of:
A composition comprising complementary fragments of a first enzyme molecule that exhibits a detectable active when associated, wherein each fragment is fused to a separate molecule.
A composition comprising complementary fragments of a multimeric enzyme, each fused to separate molecules.
A composition comprising a nucleic acid molecule coding for an enzyme fusion product, which molecule comprises sequences coding for a product selected from the group consisting of:
A method of testing for biomolecular interactions associated with:
A composition comprising a product selected from the group consisting of:
A composition comprising a nucleic acid molecule coding for an enzyme fusion product, which molecule comprises sequences coding for either:
A method of screening a cDNA library comprising performing an enzyme complementation assay wherein said assay detection means is reconstitution of enzyme activity.
A method for detecting protein-protein interactions in living organisms and or cells, which method comprises:
A method for detecting biomolecular interactions said method comprising:
A method for detecting biomolecular interactions said method comprising:
Dependencies are inferred from the claim text.